ES8607304A1 - Un procedimiento para la preparacion de derivados de espiro-hidantoina - Google Patents

Un procedimiento para la preparacion de derivados de espiro-hidantoina

Info

Publication number
ES8607304A1
ES8607304A1 ES540858A ES540858A ES8607304A1 ES 8607304 A1 ES8607304 A1 ES 8607304A1 ES 540858 A ES540858 A ES 540858A ES 540858 A ES540858 A ES 540858A ES 8607304 A1 ES8607304 A1 ES 8607304A1
Authority
ES
Spain
Prior art keywords
fch
treatment
hydantoin
derivatives
disustituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES540858A
Other languages
English (en)
Other versions
ES540858A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8607304A1 publication Critical patent/ES8607304A1/es
Publication of ES540858A0 publication Critical patent/ES540858A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • External Artificial Organs (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE ESPIRO-HIDANTOINA Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULAS (I) O (II), EN LAS QUE Z ES HIDROGENO O AMINO; FA-BFD- REPRESENTA FN-CHFCH, FCH-CHFN- O FCH-NFCH; Y X, Y, R, RK Y RL PUEDEN SER VARIOS TIPOS DE RADICALES. COMPRENDE LA REACCION DE ALQUILACION DE SODIO-HIDANTOIN-5-CARBOXILATO DE ETILO CON UNA PIRIDINA HALONITRO-DISUSTITUIDA ADECUADA; SEGUIDA DE CICLACION REDUCTIVA DEL COMPUESTO OBTENIDO, POR TRATAMIENTO CON HIERRO EN POLVO, EN PRESENCIA DE UN ACIDO, A UNA TEMPERATURA COMPRENDIDA ENTRE 20J Y 100JC. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE CATARATAS DIABETICAS, RETINOPATIAS Y NEUROPATIAS.
ES540858A 1983-05-25 1985-03-01 Un procedimiento para la preparacion de derivados de espiro-hidantoina Expired ES8607304A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/497,962 US4464380A (en) 1983-05-25 1983-05-25 Imidazolidinedione derivatives

Publications (2)

Publication Number Publication Date
ES8607304A1 true ES8607304A1 (es) 1986-06-01
ES540858A0 ES540858A0 (es) 1986-06-01

Family

ID=23979057

Family Applications (2)

Application Number Title Priority Date Filing Date
ES532736A Expired ES8600764A1 (es) 1983-05-25 1984-05-23 Un procedimiento para la preparacion de derivados de espiro-hidantoina
ES540858A Expired ES8607304A1 (es) 1983-05-25 1985-03-01 Un procedimiento para la preparacion de derivados de espiro-hidantoina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES532736A Expired ES8600764A1 (es) 1983-05-25 1984-05-23 Un procedimiento para la preparacion de derivados de espiro-hidantoina

Country Status (19)

Country Link
US (1) US4464380A (es)
EP (1) EP0127412B1 (es)
JP (1) JPS604183A (es)
KR (1) KR860001869B1 (es)
AT (1) ATE57531T1 (es)
AU (1) AU543916B2 (es)
CA (1) CA1266270A (es)
DE (1) DE3483402D1 (es)
DK (1) DK163924C (es)
ES (2) ES8600764A1 (es)
FI (1) FI78699C (es)
GR (1) GR82020B (es)
HU (1) HU190548B (es)
IE (1) IE57520B1 (es)
IL (1) IL71904A (es)
PH (1) PH21151A (es)
PL (3) PL143070B1 (es)
PT (1) PT78625A (es)
YU (2) YU43931B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
ES2187603T3 (es) * 1995-10-18 2003-06-16 Hoffmann La Roche Hidroximetilacion de tocoferoles.
BR9916371A (pt) 1998-12-19 2001-09-18 Janssen Pharmaceutica Nv Composto de espiro anti-histamìnico
WO2007091948A2 (en) * 2006-02-07 2007-08-16 Astrazeneca Ab Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4490381A (en) * 1979-11-13 1984-12-25 Imperial Chemical Industries Plc 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones
ZA806623B (en) * 1979-11-13 1981-12-30 Ici Ltd Substituted indoline-2-one derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives

Also Published As

Publication number Publication date
KR860001869B1 (ko) 1986-10-24
US4464380A (en) 1984-08-07
YU212286A (en) 1987-10-31
EP0127412A3 (en) 1987-09-02
AU543916B2 (en) 1985-05-09
ES532736A0 (es) 1985-10-16
YU43958B (en) 1989-12-31
DK250084D0 (da) 1984-05-22
HUT34194A (en) 1985-02-28
FI842079A0 (fi) 1984-05-24
YU89784A (en) 1987-04-30
IL71904A (en) 1988-01-31
ATE57531T1 (de) 1990-11-15
JPS604183A (ja) 1985-01-10
JPH0573754B2 (es) 1993-10-15
ES8600764A1 (es) 1985-10-16
PL247804A1 (en) 1985-08-13
EP0127412B1 (en) 1990-10-17
AU2856384A (en) 1984-11-29
HU190548B (en) 1986-09-29
KR840009101A (ko) 1984-12-24
DK163924C (da) 1992-09-14
FI78699C (fi) 1989-09-11
IE841294L (en) 1984-11-25
DK163924B (da) 1992-04-21
YU43931B (en) 1989-12-31
PL143290B1 (en) 1988-02-29
EP0127412A2 (en) 1984-12-05
IE57520B1 (en) 1993-05-19
PL252850A1 (en) 1985-11-19
IL71904A0 (en) 1984-09-30
GR82020B (es) 1984-12-12
DK250084A (da) 1984-11-26
CA1266270A (en) 1990-02-27
DE3483402D1 (de) 1990-11-22
FI842079A7 (fi) 1984-11-26
PT78625A (en) 1984-06-01
FI78699B (fi) 1989-05-31
ES540858A0 (es) 1986-06-01
PH21151A (en) 1987-07-30
PL143070B1 (en) 1988-01-30

Similar Documents

Publication Publication Date Title
ES8206491A1 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina.
ES8303918A1 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
ES8608874A1 (es) Un procedimiento para la preparacion de una 2-(1h)-quinolona
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
CY1350A (en) Improvements in or relating to 3-aryloxy-3-phenylpropylamines
ES8600211A1 (es) Un procedimiento para la preparacion de nuevos derivados arilfenilicos
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
DK0513351T3 (da) 2-Nitroimidazolderivat, fremstilling deraf og strålingssensibilisator indeholdende samme som aktiv bestanddel
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
ES8301978A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles.
ES8301980A1 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES8801276A1 (es) Procedimiento para preparar nuevos derivados imidazo
ES8702343A1 (es) Un procedimiento para la produccion de un derivado de diami-das de n-acilaminoacidos
ES8301926A1 (es) Un procedimiento para la preparacion de un compuesto
ES8303404A1 (es) Procedimiento para preparar 3-amino-sidnoniminas sustituidas.
ES2051954T3 (es) 2-aminotiazoles substituidos.
ES8502086A1 (es) Procedimiento para la obtencion de derivados de feniletilamina
DK0452204T3 (da) Hidtil ukendte 3-aminochromanderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES8503676A1 (es) Procedimiento de producir derivados de acido oxazolacetico
ES535411A0 (es) Procedimiento para preparar nuevos derivados del acido 4-fenil-4-oxo-buten-2-oico
IL64081A0 (en) Novel guanidine derivatives
ES8202818A1 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
ES8800224A1 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas
ES8205215A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido acetico.
ES8308551A1 (es) Procedimiento para la preparacion de derivados de tiazolina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519